Imunon, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.2% | -33.7% | -28.0% |
| FY2022 | -122.4% | -101.7% | -81.6% |
| FY2023 | -145.8% | -145.8% | -89.0% |
| FY2024 | -438.7% | -438.7% | -191.6% |
| FY2025 | -205.3% | -205.3% | -118.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -37.2% | -33.7% | -28.0% |
| FY2022 | -122.4% | -101.7% | -81.6% |
| FY2023 | -145.8% | -145.8% | -89.0% |
| FY2024 | -438.7% | -438.7% | -191.6% |
| FY2025 | -205.3% | -205.3% | -118.0% |